Ashurst

Generic drug maker Sun Pharma has succeeded in invalidating Otsuka Pharmaceutical’s patent for an injectable, controlled release form of the Japanese drug maker's top-selling antipsychotic Abilify.

Ahead of an eight-week trial in an investor class action in July, ratings agency S&P has lost its bid to throw out the entirety of the expert evidence in the case.

A judge has rejected HSU secretary Diana Asmar's argument that a case against her over an alleged $2.7 million false invoicing scheme should be stayed because criminal charges were “on the cards”.

Defunct Greensill Group has filed a bid to disqualify a recently appointed Federal Court judge from hearing a case over its $1.7 billion collapse.

British banking giant HSBC could face a new claim in ASIC proceedings alleging it failed to adequately protect customers from scams, a court has heard.

Amp Energy has completed the financing for the first stage of construction on a Carlyle Group-backed battery energy storage system in South Australia.

Power company Callide has been hit with a $9 million penalty for “very serious” contraventions of the National Electricity Rules that led to an explosion at a coal-fired power station.

Noumi and auditor Deloitte will pay $43 million to resolve a class action alleging the company misled investors about its inventory, and the class action will make a play for a $5 million penalty agreed to in ASIC proceedings.

Real estate lawyer Vicki Aron has joined Clayton Utz's Sydney office as a partner after seven years at Ashurst.

The liquidators for landbanking company Aviation 3030 can recover half of a $3.4 million landholder duty from a former director, after a judge found they reaped benefits from indirect ownership in land sold for $135 million in 2018.